News Headlines Article

Up to 1 in 4 Patients Skip Oral Cancer Drugs on Costs
Health Leaders Media

High co-payment costs prompt between 6% and 25% of oncology patients to walk away from the pharmacy counter without filling their prescriptions for eight oral cancer drugs, according to a report funded by five large pharmacy manufacturers.

According to the report, 6% of oncology patients whose prescription co-payment was $100 or less decided to void the purchase after learning the cost.